Ad Scientiam Launches International Study to Assess Disability Progression in Multiple Sclerosis With MSCopilot

Contributed by: ACCESS Newswire

Logo

Tags

Ad Scientiam

Healthcare & Pharmaceutical

Partnerships

More Like This

All Digital Mobility Outcomes developed by the Mobilise-D consortium will be accessible through the Empatica Health Monitoring Platform (Photo: Business Wire)

Empatica Announces Integration of Mobilise-D Mobility Outcomes, Advancing Toward Unified Solution for Clinical Professionals

Exidavnemab phase 2a study expanded to include MSA patients

PR Newswire associated0

medac cooperates with Scienta Lab to generate new insights in rheumatology care with AI-powered solutions

Lundbeck to share pipeline data and key insights into the progression of rare disease, Multiple System Atrophy, at International MSA Congress in Boston

Tiziana Life Sciences Announces Dosing of Additional Patients in Multiple Sclerosis Expanded Access Program

SciBase Announces Positive Findings in Case Study Monitoring Treatment Outcomes in Atopic Dermatitis Patient

ONWARD Medical to Advance Parkinson’s Disease Pipeline with Support from The Michael J. Fox Foundation and US Department of Defense

Tiziana Life Sciences Announces Positive Six-Month Clinical Results in Multiple Sclerosis Patients Treated with Intranasal Foralumab